Primary and metastatic liver tumors are an increasing global health problem, with
hepatocellular carcinoma (HCC) now being the third leading cause of cancer-related …

Locally ablative therapies have an increasing role in the effective multidisciplinary approach
towards the treatment of both primary and metastatic liver tumors. In patients who are not …

Traditionally, the only curative option for patients with liver tumors has been hepatic
resection. Unfortunately, only 10%-20% of patients with liver tumors can undergo surgical …

Recently, several minimally invasive, image-guided therapies have been developed for the
local treatment of hepatocellular carcinoma (HCC) and hepatic metastases in patients who …

Six existing minimally invasive techniques for the treatment of primary and secondary
malignant hepatic tumors—radio-frequency ablation, microwave ablation, laser ablation …

This is a review of minimally invasive therapy options for liver tumors, such as highly focused
ultrasound, microwave ablation, and irreversible electroporation, as well as new aspects of …

Liver cancers are the second most frequent cause of global cancer-related mortality of which
90% are attributable to hepatocellular carcinoma (HCC). Despite the advent of screening …

Minimally invasive therapies are gaining increasing attention as an alternative to standard
surgical therapies in the treatment of primary hepatocellular carcinoma. These include …

Hepatocellular carcinoma (HCC) is the fifth most common cancer and the third most
common cause of cancer-related death worldwide. There have been great improvements in …

Surgical resection is often the first-line treatment option for primary and select metastatic
hepatic malignancies. A minority of patients with hepatocellular carcinoma undergo …